Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 2020. Start Trial.
Date Value
June 30, 2026 -47.18M
March 31, 2026 -46.44M
December 31, 2025 -46.68M
September 30, 2025 -44.18M
June 30, 2025 -43.79M
March 31, 2025 -44.70M
December 31, 2024 -44.79M
September 30, 2024 -44.81M
June 30, 2024 -43.08M
March 31, 2024 -38.62M
December 31, 2023 -33.04M
September 30, 2023 -27.34M
Date Value
June 30, 2023 -25.22M
March 31, 2023 -31.73M
December 31, 2022 -30.59M
September 30, 2022 -36.24M
June 30, 2022 -32.23M
March 31, 2022 -21.13M
December 31, 2021 -18.53M
September 30, 2021 -10.10M
June 30, 2021 -8.997M
March 31, 2021 -7.838M
December 31, 2020 -5.629M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
IDEXX Laboratories, Inc. 1.233B
Neogen Corp. 31.90M
QuidelOrtho Corp. -211.20M
Aspira Women's Health, Inc. -5.113M
VolitionRX Ltd. -18.86M